Blood Pressure in Children and Adolescents with Cushing's Syndrome before and after Surgical Cure

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 6, 1997, Pages 1734-1738

  Magiakou, Maria Alexandra ^a,b   Mastorakos, George ^a,b   Zachman, Keith ^a   Chrousos, George P ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CHILD; CUSHING SYNDROME; DIASTOLE; FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; POSTOPERATIVE PERIOD; PRESCHOOL CHILD; SYSTOLE; TIME;

ADOLESCENT; ADULT; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; CUSHING SYNDROME; DIASTOLE; FEMALE; HUMANS; HYDROCORTISONE; MALE; POSTOPERATIVE PERIOD; SYSTOLE; TIME FACTORS;

EID: 0031156409     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.82.6.3985     Document Type: Article

References (49)

1. Jones KL. 1990 The Cushing's syndromes. Pediatr Clin North Am. 37: 1313-1329.
2. Etxabe J, Vazquez JA. 1994 Morbidity, and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol. 40:479-484.
3. Magiakou MA, Mastorakos G, Oldfield EH, et al. 1994 Cushing's syndrome in children, and adolescents: Presentation, diagnosis and therapy. N Engl J Med. 331:629-636.
4. Orth DN, Kovacs WJ, DeBold CR. 1992 The adrenal cortex. In: Wilson JD, Foster DW, eds. Williams textbook of endocrinology. Philadelphia: WB Saunders; 489-619.
5. Ambrosi B, Faglia G, and the multicenter pituitary tumor study group, Lombardia region. Epidemiology of pituitary tumors. In: Faglia G, Beck-Peccoz P, Ambrosi A, Travaglini P, Spada A, eds. Pituitary adenomas. New trends in basic and clinical research. Amsterdam: Excerpta Medica; 159-168.
6. Aron DC, Findling JW, Tyrrell JB. 1987 Cushing's disease. Endocrinol Metab Clin North Am. 16:705-730.
7. Boggan JE, Tyrrell JB, Wilson CB. 1983 Transsphenoidal microsurgical management of Cushing's disease: report of 100 cases. J Neurosurg. 59:195-200.
8. Chandler WF, Schteingart DE, Lloyd RV, Mckeever RV, Ibara-Perez G. 1987 Surgical treatment of Cushing's disease. J Neurosurg. 66:204-212.
9. Kageyama N, Kuwayama A, Tabahashi T, Ichihara K, Kato T, Yokoe T. 1983 Microsurgical results in 90 cases of Cushing's disease. In: Lamberts SWJ, ed. Trends in diagnosis and treatment of pituitary adenomas. Amsterdam: Free University; 325-333.
10. Krieger DT. 1982 Cushing's disease: medical therapy. In: Givens JR, ed. Hormone-secreting pituitary tumors. Chicago: Year Book Medical Publishers; 167-198.
11. Ludecke DK, Niedworok G. 1985 Results of microsurgery in Cushing's disease, and effect on hypertension. Cardiology. 72:91-94.
12. Mampalam TJ, Tyrrell JB, Wilson CB. 1988 Transsphenoidal microsurgery for Cushing's disease. A report of 216 cases. Ann Intern Med. 109:487-493.
13. Suzuki H, Handa M, Kondo K, Saruta T. 1982 Role of renin-angiotensin system in glucocorticoid hypertension in rats. Am J Physiol. 243:E48-E51.
14. Nakamoto H, Suzuki H, Kageyama Y, Murakami M, Ohishi A, Saruta T. 1991 Characterization of hemodynamics, and neuroendocrine hormones in dexamethasone induced hypertension in dogs. Clin Exp Hypertens [A]. 13:587-606.
15. Udelsman R, Ramp J, Gaducci WT, et al. 1986 Adaptation during surgical stress: a reevaluation of the role of glucocorticoids. J Clin Invest. 77:1377-1381.
16. Saruta T, Suzuki H, Handa M, Igarashi Y, Kondo K, Senba S 1986 Multiple factors contribute to the pathogenesis of hypertension in Cushing's syndrome. J Clin Endocrinol Metab. 62:275-279.
17. Waeber B, Gavras H, Bresnaham MR, Gavras I, Brunner HR. 1983 Role of vasoconstrictor systems in experimental glucocorticoid-hypertension in rats. Clin Sci. 65:255-261.
18. Nakamoto H, Suzuki H, Kageyama Y, et al. 1992 Depressor systems contribute to hypertension induced by glucocorticoid excess in dogs. J Hypertens. 10:561-569.
19. Handa M, Kondo K, Suzuki H, Saruta T. 1983 Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats. Clin Sci. 65:37-42.
20. Conway J. 1986 Hemodynamics in mineralocorticoid hypertension. In: Zanchetti A, Tarazi RC, eds. Handbook of hypertension. Vol 7. Pathophysiology of hypertension-cardiovascular aspects. Amsterdam: Elsevier Publishers; 217-224.
21. Kageyama Y, Bravo EL. 1988 Hypertensive mechanisms associated with centrally administered alsosterone in dogs. Hypertension. 11:750-753.
22. Gomez-Sanchez EP. 1986 Intracerebroventricular infusion of aldosterone induces hypertension in rats. Endocrinology. 118:819-823.
23. Van den Berg DTWM, de Kloet ER, van Dijken HH, de Jong W. 1990 Differential central effects of mineralocorticoid, and glucocorticoid agonists and antagonists on blood pressure. Endocrinology. 126:118-124.
24. de Kloet ER, van den Berg DTWM, van Dijken HH, van der Peet E, Sutanto W, de Jong W. 1989Brain corticosteroid receptors, and central cardiovascular control. In: Mantero F, Takeda R, Scoggins BA, Biglieri EG, Funder JW, eds. The adrenal and hypertension: from cloning to clinic. New York: Raven Press; 121-133.
25. Tonolo G, Soro A, Madeddu P, et al. 1993 Effect of chronic intracerebroventricular dexamethasone on blood pressure in normotensive rats. Am J Physiol. 264:E843-E847.
26. Biglieri EG, Irony I, Kater CE. 1990Chapter 100. Adrenocortical forms of human hypertension. In: Laragh JH, Brenner BM, eds. Hypertension, Vol 2. New York: Raven Press; 1609-1623.
27. Marshall WA, Tanner JM. 1969 Variations in pattern ot pubertal changes in girls. Arch Dis Child. 44:291-303.
28. Zachmann M, Prader A, Kund HP, Hafliger H, Budlinger H. 1974 Testicular volume during adolescence. Cross-sectional, and longitudinal studies. Helv Paediatr Acta. 29(1):61-72.
29. Gomez MT, Malozowski S, Winterer J, Vamvakopoulos NC, Chrousos GP. 1991 Urinary free cortisol values in normal children, and adolescents. J Pediatr. 118:256-258.
30. Cheitlin MD. 1993 Systemic hypertension. In: Sokolow M, McIlroy MB, eds. Clinical cardiology. 6th ed. Norwalk: Connecticut: Appleton & Lange; 247.
31. Report of the Second Task Force on Blood Pressure Control in Children. 1987 Pediatrics 79:1-25, and update, 1996 98:649-658.
32. Report of the Second Task Force on Blood Pressure Control in Children. 1987 Pediatrics 79:1-25, and update, 1996 98:649-658.
33. Murphy BEP. 1968 Clinical evaluation of urinary cortisol determinations by competitive protein-binding radioassay. J Clin Endocrinol Metab. 28:343-348.
34. Ritchie CM, Sheridan B, Fraser R, et al. 1990 Studies on the pathogenesis of hypertension in Cushing's disease, and acromegaly. Q J Med. 280:855-867.
35. Kaplan SA. 1979 Disorders of the adrenal cortex. Pediatr Clin North Am. 26:65-76.
36. Gomez MT, Magiakou MA, Mastorakos G, Chrousos GP. 1993 The pituitary corticotroph is not the rate limiting step in the postoperative recovery of the hypothalamic-pituitary-adrenal axis in patients with Cushing's syndrome. J Clin Endocrinol Metab. 77:173-177.
37. Magiakou MA, Mastorakos G, Gomez MT, Rose SR, Chrousos GP. 1994 Suppressed spontaneous, and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure. J Clin Endocrinol Metab. 78:131-137.
38. Magiakou MA, Mastorakos G, Chrousos GP. 1994 Final stature in patients with endogenous Cushing's syndrome. J Clin Endocrinol Metab. 79: 1082-1085.
39. Mitsiades NS, Stratakis CA, Mastorakos G, Magiakou MA, Mitsiades CS. Skin manifestations in Cushing's syndrome in children, and adolescents before and after surgical treatment. Proc of the 77th Annual Meeting of The Endocrine Society, Washington, DC, 1995, p 331 (Abstract P2-161).
40. Beegom R, Beegom R, Niaz MA, Singh RB. 1995 Diet, central obesity, and prevalence of hypertension in the urban population of South India. Int J Cardiol. 51:183-191.
41. Bronner LL, Kanter DS, Manson JE. 1995 Primary prevention of stroke. N Engl J Med. 333:1392-1400.
42. National Research Council. 1989 Diet and health: implications for reducing chronic disease risk. Washington DC: National Academy Press.
43. Horton ES. 1981 The role of exercise in the treatment of hypertension in obesity. Int J Obes. [Suppl 1]5:165-171.
44. Mc Mohan S, Cutler J, Britain E, Higgins M. 1987 Obesity, and hypertension: epidemiological and clinical issues. Eur Heart J. [Suppl B]7:57-70.
45. Peeke PM, Chrousos GP. 1995 Hypercortisolism, and obesity. Ann NY Acad Sci. 771:665-676.
46. Kanal H, Tokunaga K, Fujioka S, Yamashita S, Kameda-Takemura KK, Matzuzawa Y. 1996 Decrease in intra-abdominal visceral fat may reduce blood pressure in obese hypertensive women. Hypertension. 27:125-129.
47. Su HY, Sheu WH, Chin HM, Jeng CY, Chen YD, Reaven GM. 1995 Effect of weight loss on blood pressure, and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens. 8:1067-1071.
48. Gibbons GH. 1995 Vascular remodeling in hypertension: role of autocrine-paracrine factors. Blood Press. [Suppl]2:49-54.
49. Bamberger CM, Schulte HM, Chrousos GP. 1996 Molecular determinants of glucocorticoid receptor function, and tissue sensitivity to glucocorticoids. Endocr Rev. 17:245-261.